Research Author

Torben Lorentzen

Herlev Hospital
Copenhagen University Hospital

ORCID OpenAlex profile

0Studies tracked

0Claims cite

0Videos use

Average study score: 44/100

Bibliography

Studies by this author

1 study attributed to Torben Lorentzen on the platform. Click a card to read the full analysis.

Study

Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma

Phase I dose-escalation study evaluating safety, immunogenicity, and efficacy of personalized neoantigen vaccine EVX-01-CAF09b added to anti-PD-1 in metastatic melanoma.

Moderate

Sofie Kirial Mørk,Signe K. Skadborg,Benedetta Albieri+22 more

Read analysis